Meiser, B M <br/><br/>
Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.  [electronic resource] 

 -  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation  Aug 1997 
 - 795-800 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1053-2498 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Acute Disease<br/>Adult<br/>Chronic Disease<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Graft Rejection--drug therapy<br/>Heart Transplantation--immunology<br/>Heart-Lung Transplantation--immunology<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Lung Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Muromonab-CD3--administration & dosage<br/>Opportunistic Infections--chemically induced<br/>Survival Analysis<br/>Tacrolimus--administration & dosage<br/>Treatment Outcome